Among these, TP53 is associated with a poor prognosis, and iCCA patients with TP53 mutations are more likely to be HBsAg-positive, suggesting that the p53-mediated pathway may contribute to tumorigenesis in HBV-induced iCCA, such as HCC [127]. The gene discussed is TP53; the disease is hepatocellular carcinoma.